Neurofibromatosis and childhood leukaemia
1996

Neurofibromatosis and Childhood Leukaemia

Commentary Evidence: moderate

Author Information

Author(s): A Zvulunov, A Metzker

Primary Institution: Soroka Medical Center, Beer-Sheva, Israel; Shneider's Children's Medical Center, Petah-Tiqva, Israel

Hypothesis

Children with neurofibromatosis type 1 (NF-1) and cutaneous juvenile xanthogranuloma (JXG) may have a greater risk of juvenile chronic myelogenous leukaemia (JCML).

Conclusion

The study suggests that the risk of JCML in children with NF-1 and JXG is significantly higher than in those without JXG.

Supporting Evidence

  • The relative risk for JCML in children with NF-1 and JXG is estimated to be 20- to 32-fold greater than in those without JXG.
  • The frequency of JCML among children with NF-1 and JXG is between 1/52 and 1/84.
  • This frequency is 1700- to 5500-fold higher than in the general population.

Takeaway

Kids with a condition called neurofibromatosis and certain skin bumps might get a type of blood cancer much more often than other kids.

Methodology

Data from published cases of NF-1, JXG, and JCML were analyzed to estimate relative risks.

Limitations

The inclusion of a patient with JXG may have skewed the risk calculations for those without JXG.

Participant Demographics

Children with neurofibromatosis type 1 and juvenile xanthogranuloma.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication